GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Ltd (BOM:500680) » Definitions » Price-to-Owner-Earnings

Pfizer (BOM:500680) Price-to-Owner-Earnings : 25.30 (As of May. 06, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Pfizer Price-to-Owner-Earnings?

As of today (2024-05-06), Pfizer's share price is ₹4211.95. Pfizer's Owner Earnings per Share (TTM) ended in Mar. 2023 was ₹166.49. It's Price-to-Owner-Earnings for today is 25.30.


The historical rank and industry rank for Pfizer's Price-to-Owner-Earnings or its related term are showing as below:

BOM:500680' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 6.24   Med: 38.11   Max: 479.01
Current: 25.3

During the past 13 years, the highest Price-to-Owner-Earnings of Pfizer was 479.01. The lowest was 6.24. And the median was 38.11.


BOM:500680's Price-to-Owner-Earnings is ranked better than
56.8% of 419 companies
in the Drug Manufacturers industry
Industry Median: 28.28 vs BOM:500680: 25.30

As of today (2024-05-06), Pfizer's share price is ₹4211.95. Pfizer's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹109.76. Therefore, Pfizer's PE Ratio for today is 38.37.

As of today (2024-05-06), Pfizer's share price is ₹4211.95. Pfizer's EPS without NRI for the trailing twelve months (TTM) ended in was ₹111.85. Therefore, Pfizer's PE Ratio without NRI for today is 37.66.

During the past 13 years, Pfizer's highest PE Ratio without NRI was 57.31. The lowest was 13.94. And the median was 33.89.


Pfizer Price-to-Owner-Earnings Historical Data

The historical data trend for Pfizer's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Price-to-Owner-Earnings Chart

Pfizer Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 69.61 35.03 42.63 26.75 20.83

Pfizer Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 20.83 - - -

Competitive Comparison of Pfizer's Price-to-Owner-Earnings

For the Drug Manufacturers - General subindustry, Pfizer's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pfizer's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Pfizer's Price-to-Owner-Earnings falls into.



Pfizer Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Pfizer's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=4211.95/166.49
=25.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pfizer  (BOM:500680) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Pfizer Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Pfizer's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Pfizer (BOM:500680) Business Description

Traded in Other Exchanges
Address
The Capital, 1802/1901, 18th Floor, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Pfizer Ltd is a major drug manufacturing company that focuses on a global portfolio of medical products. The company works across developed and emerging markets to advance treatments through its two segments, Pfizer Innovative Health and Pfizer Essential Health. The vast majority of the company's revenue is derived from the manufacture and sale of biopharmaceutical products. most of the company's sales are generated by its Innovative Health segment. While the company operates across a wide span of international markets, most of the company's revenue is generated in India.

Pfizer (BOM:500680) Headlines

No Headlines